TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/11/2025
Voltar para busca
Dado oficial do USPTO
ASTER INSIGHTS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ASTER INSIGHTS
ST13
US500000097849603Classe
42, 44
Pedido
97849603
Registro
7739987
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
16/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
21/03/2023
Data de registro
25/03/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/03/2025
Última transação
16/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
14/04/2023
Primeiro uso no comércio
14/04/2023
Código do desenho
4
Tipo de titular
03
Localização do titular
Hudson, FL
Examinador
WEIGLE,KATHERINE CONNOLLY
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
M2Gen, Corp.
Representantes
Karen K. Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Providing an electronic database for the collection and storage of clinical and molecular data derived from a patientan electronic database featuring medical and scientific research information in the field of human clinical and molecular data analysis for aiding medical diagnosticsdiscovery and development and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases; medical and scientific research data analysis and bioinformatics consulting services relating theretocomputer software consultingproviding online non-downloadable computer software platforms for analyzing medical and scientific research datascientific research data analytics consulting in connection with an electronic database for the collection and storage of medical and scientific research information in the fields of clinical and molecular data accumulated for aiding medical diagnosticdiscovery and development and prognostics and evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases; providing an Internet-accessible website portal featuring medical records for use by physicianspatients and researchers for the storage and accessibility of electronic medical research data in the field of human clinical and molecular data and analysis for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness; providing consulting services relating thereto for the aforementioned services
Classe 44
Providing an electronic database for the collection and storage of clinical and molecular data derived from a patientan electronic database featuring medical information in the field of human clinical and molecular data analysis for aiding medical diagnosticsdiscovery and development and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases; Health care servicesproviding a database in the field of cancer and other disease medical information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Providing a database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectivenessproviding medical information data regarding tumor-specific molecular signaturesproviding objective medical information data on the effectiveness of a drug and/or diagnostic testproviding evidence-based treatment protocols by effectively comparing standard treatment therapies with clinical outcomes; collection and analysis of data services in the field of human clinical and molecular data for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseasesmedical services in the nature of matching particular patients to a particular drugtreatmenttherapy or clinical trial by the specific molecular signature of the patient; providing an Internet-accessible website portal featuring medical records for use by physicianspatients and researchers for the storage and accessibility of electronic medical information data in the field of human clinical and molecular data and analysis for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness; providing consulting services relating thereto for the aforementioned services.
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/11/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/11/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/11/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/03/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
25/03/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
28/02/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
28/02/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
22/02/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
22/02/2025
IUAF
USE AMENDMENT FILED
11/12/2024
EISU
TEAS STATEMENT OF USE RECEIVED
11/12/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
18/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/04/2024
PUBO
PUBLISHED FOR OPPOSITION
23/04/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/03/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
21/03/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/03/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
21/03/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
28/02/2024
GNRT
NON-FINAL ACTION E-MAILED
28/02/2024
CNRT
NON-FINAL ACTION WRITTEN
28/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/02/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/12/2023
GNRT
NON-FINAL ACTION E-MAILED
18/12/2023
CNRT
NON-FINAL ACTION WRITTEN
18/12/2023
DOCK
ASSIGNED TO EXAMINER
15/12/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/04/2023
NWAP
NEW APPLICATION ENTERED
24/03/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ASTER INSIGHTS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.